Ignite Creation Date:
2025-12-24 @ 1:56 PM
Ignite Modification Date:
2025-12-28 @ 3:16 PM
Study NCT ID:
NCT04596995
Status:
TERMINATED
Last Update Posted:
2024-02-05
First Post:
2020-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Sponsor:
UCB Biopharma SRL
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-15
First Submit QC Date:
None
Study First Post Date:
2020-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-20
Results First Submit QC Date:
None
Results First Post Date:
2024-02-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-02
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL